This content is machine translated Dyslipidemia: "Treat-to-target" Risk-adapted individual LDL-C targets Together with arterial hypertension and diabetes mellitus, lipid metabolism disorders are among the most important modifiable cardiovascular risk factors. In addition to statins, various modern substance classes are now available...…
View Post 6 min This content is machine translated Risk management for diabetes and severe mental illness Critically question statin prescribing in patients with T2D and SMI Differences in mental health outcomes in diabetic patients with concomitant severe mental illness are often associated, at least in part, with suboptimal cardiovascular risk monitoring. A Dutch-Scottish research group investigated…
View Post 5 min This content is machine translated Metabolic Dysfunction-Associated Steatotic Liver Disease Cardiology and hepatology in one boat Metabolic dysfunction has far-reaching negative effects on the body, which can manifest as cardiovascular and liver disease. Traditionally, these conditions have been treated in an organ-centered manner, resulting in isolated…
View Post 3 min This content is machine translated LDL cholesterol Bempedoic acid and cardiovascular outcomes in statin intolerant patients Treatment of elevated LDL cholesterol levels is a central component of modern therapy to reduce the risk of serious cardiovascular events in patients with primary or secondary prevention. However, 7%…
View Post 8 min This content is machine translated StaRT-CABG Study Intensified statin therapy before coronary artery bypass graft surgery? There is evidence that high-dose statin loading before percutaneous coronary revascularization improves outcomes in patients receiving long-term statins. Therefore, the aim of a recent study was to analyze the effects…
View Post 7 min This content is machine translated CLEAR Outcomes Study New results on bempedoic acid Statin-intolerant patients represent a difficult patient group to treat in lipid management. Now, with the CLEAR Outcomes study, it has been shown that a therapeutic option with a beneficial effect…
View Post 6 min This content is machine translated Cardiovascular medicine Effective treatment management for optimized outcome More than 30,000 professionals from 174 countries addressed the results of current research at the ESC Congress in Barcelona this year. Topics ranged from prevention to imaging, digital health and…
View Post 10 min This content is machine translated New AGLA guidelines Dyslipidemia – when to see a specialist? “The lower the better” – the approach to lower cholesterol levels as much as possible in patients at cardiovascular risk is more relevant than ever, according to the update of… CME-Test
View Post 5 min This content is machine translated Chronic coronary syndrome Risk stratification in coronary artery disease – an update. Coronary CT is highly ranked for the work-up algorithm in the updated European Society of Cardiology (ESC) guidelines. Calcification is an important prognostic indicator and has therapeutic implications. Among other…
View Post 2 min This content is machine translated Prevention of cardiovascular diseases How useful are statins in primary prevention? Question: How well does rosuvastatin (Crestor®) 10 mg/d protect against cardiovascular events in patients at intermediate cardiovascular risk?
View Post 6 min This content is machine translated ACC Congress in Chicago Cholesterol management under the microscope Two studies in the field of lipid therapy caused a stir at the ACC Congress in Chicago. HOPE-3 presented a pragmatic approach to primary prevention for discussion. The study showed…
